NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis
NYSE:NUS • US67018T1051
8.71 USD
+0.05 (+0.58%)
At close: Feb 20, 2026
8.71 USD
0 (0%)
After Hours: 2/20/2026, 8:04:00 PM
Overall NUS gets a fundamental rating of 5 out of 10. We evaluated NUS against 36 industry peers in the Personal Care Products industry. NUS has only an average score on both its financial health and profitability. NUS has a bad growth rate and is valued cheaply.
1. Profitability
1.1 Basic Checks
- NUS had positive earnings in the past year.
- NUS had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: NUS reported negative net income in multiple years.
- NUS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.69%, NUS is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
- NUS has a Return On Equity of 13.70%. This is amongst the best in the industry. NUS outperforms 80.56% of its industry peers.
- With a Return On Invested Capital value of 4.08%, NUS perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 11.55%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROIC | 4.08% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
1.3 Margins
- NUS has a Profit Margin of 7.02%. This is in the better half of the industry: NUS outperforms 75.00% of its industry peers.
- NUS has a Operating Margin of 3.87%. This is comparable to the rest of the industry: NUS outperforms 50.00% of its industry peers.
- In the last couple of years the Operating Margin of NUS has declined.
- NUS has a Gross Margin (67.20%) which is in line with its industry peers.
- NUS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% |
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
- There is no outstanding debt for NUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 3.71 indicates that NUS is not in any danger for bankruptcy at the moment.
- NUS's Altman-Z score of 3.71 is fine compared to the rest of the industry. NUS outperforms 75.00% of its industry peers.
- The Debt to FCF ratio of NUS is 4.29, which is a neutral value as it means it would take NUS, 4.29 years of fcf income to pay off all of its debts.
- NUS has a better Debt to FCF ratio (4.29) than 77.78% of its industry peers.
- NUS has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.26, NUS is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Altman-Z | 3.71 |
ROIC/WACC0.49
WACC8.26%
2.3 Liquidity
- A Current Ratio of 2.15 indicates that NUS has no problem at all paying its short term obligations.
- Looking at the Current ratio, with a value of 2.15, NUS is in line with its industry, outperforming 50.00% of the companies in the same industry.
- A Quick Ratio of 1.45 indicates that NUS should not have too much problems paying its short term obligations.
- NUS's Quick ratio of 1.45 is in line compared to the rest of the industry. NUS outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 |
3. Growth
3.1 Past
- NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.76%, which is quite impressive.
- Measured over the past years, NUS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.78% on average per year.
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.89%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- NUS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.05% yearly.
EPS Next Y11.18%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- NUS is valuated cheaply with a Price/Earnings ratio of 6.75.
- NUS's Price/Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 97.22% of the companies in the same industry.
- NUS is valuated cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 6.07, the valuation of NUS can be described as very cheap.
- NUS's Price/Forward Earnings ratio is rather cheap when compared to the industry. NUS is cheaper than 91.67% of the companies in the same industry.
- NUS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.75 | ||
| Fwd PE | 6.07 |
4.2 Price Multiples
- NUS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NUS is cheaper than 97.22% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, NUS is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.96 | ||
| EV/EBITDA | 3.42 |
4.3 Compensation for Growth
- NUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- NUS has a Yearly Dividend Yield of 2.77%.
- NUS's Dividend Yield is a higher than the industry average which is at 1.61.
- NUS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.77% |
5.2 History
- The dividend of NUS decreases each year by -30.50%.
- NUS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- NUS pays out 10.87% of its income as dividend. This is a sustainable payout ratio.
DP10.87%
EPS Next 2YN/A
EPS Next 3YN/A
8.71
+0.05 (+0.58%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-12 2026-02-12/amc
Earnings (Next)05-06 2026-05-06
Inst Owners77.1%
Inst Owner Change1.79%
Ins Owners2.11%
Ins Owner Change14.18%
Market Cap424.61M
Revenue(TTM)N/A
Net Income(TTM)109.61M
Analysts45
Price TargetN/A
Short Float %3.7%
Short Ratio3.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.77% |
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27 2026-02-27 (0.06)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.75 | ||
| Fwd PE | 6.07 | ||
| P/S | 0.27 | ||
| P/FCF | 7.96 | ||
| P/OCF | 4.75 | ||
| P/B | 0.53 | ||
| P/tB | 0.63 | ||
| EV/EBITDA | 3.42 |
EPS(TTM)1.29
EY14.81%
EPS(NY)1.43
Fwd EY16.47%
FCF(TTM)1.09
FCFY12.56%
OCF(TTM)1.83
OCFY21.07%
SpS32.01
BVpS16.41
TBVpS13.78
PEG (NY)0.6
PEG (5Y)N/A
Graham Number21.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.69% | ||
| ROE | 13.7% | ||
| ROCE | 5.16% | ||
| ROIC | 4.08% | ||
| ROICexc | 5.21% | ||
| ROICexgc | 6.05% | ||
| OM | 3.87% | ||
| PM (TTM) | 7.02% | ||
| GM | 67.2% | ||
| FCFM | 3.42% |
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 4.29 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 64.7% | ||
| Cap/Sales | 2.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.96% | ||
| Profit Quality | 48.67% | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.45 | ||
| Altman-Z | 3.71 |
F-Score6
WACC8.26%
ROIC/WACC0.49
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
EPS Next Y11.18%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.89%
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%
NU SKIN ENTERPRISES INC - A / NUS FAQ
Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?
ChartMill assigns a fundamental rating of 5 / 10 to NUS.
What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?
ChartMill assigns a valuation rating of 8 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.
How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?
NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for NUS stock?
The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 6.75 and the Price/Book (PB) ratio is 0.53.
Can you provide the dividend sustainability for NUS stock?
The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 10.87%.